Does predialysis nephrology care influence patient survival after initiation of dialysis?

Kidney International

Volumn 67, Issue 3, 2005, Pages 1038-1046

  Khan, Samina S ^a   Xue, Jay L ^b   Kazmi, Waqar H ^b   Gilbertson, David T ^b   Obrador, Gregorio T ^b   Pereira, Brian J G ^b   Collins, Allan J ^b  

^a TUFTS MEDICAL CENTER   (United States)

^b NONE

Author keywords

Chronic; Erythropoietin; Kidney failure; Mortality; Nephrology care; Recombinant; Renal dialysis; Survival

Indexed keywords

AGED; ARTICLE; COMORBIDITY; CONTROLLED STUDY; DIALYSIS; FEMALE; HEART DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAID; MEDICARE; MORTALITY; NEPHROLOGY; PATIENT CARE; PRIORITY JOURNAL; SURVIVAL; TIME; CHRONIC KIDNEY FAILURE; COHORT ANALYSIS; MIDDLE AGED; PATIENT REFERRAL; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDY; RISK FACTOR;

AGED; COHORT STUDIES; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; NEPHROLOGY; REFERRAL AND CONSULTATION; RENAL DIALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 20844461909     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2005.00168.x     Document Type: Article

References (61)

1. PLANTE C: 1971 Medicare amendment: Reflections on the passage of the end-stage renal disease Medicare program. Am J Kidney Dis 35:S45-S48, 2000
2. US RENAL DATA SYSTEM: USRDS 1999 Annual Data Report, Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 1999
3. USRDS 2001 ANNUAL DATA REPORT: Atlas of End-Stage Renal Disease in the United States, Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2001
4. HELD P, BRUNNER F, ODAKA M, et al: Five-year survival for end-stage renal disease patients in the United States, Europe, and Japan, 1982 to 1987. Am J Kidney Dis 15:451-457, 1990
5. KEANE WF, COLLINS AJ: Influence of co-morbidity on mortality and morbidity in patients treated with hemodialysis. Am J Kidney Dis 24:1010-1018, 1994
6. PORT FK, ASHBY VB, DHINGRA RK, et al: Dialysis dose and body mass index are strongly associated with survival in hemodialysis patients. J Am Soc Nephrol 13:1061-1066, 2002
7. OWEN WF: Status of hemodialysis adequacy in the United States: Does it account for improved patient survival? Am J Kidney Dis 32:S39-43, 1998
8. PARFREY P, FOLEY R: The clinical epidemiology of cardiac disease in chronic renal failure. J Am Soc Nephrol 10:1606-1615, 1999
9. KLAHR S, LEVEY AS, BECK GJ, et al, for the Modification of Diet in Renal Disease Study Group: The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. N Engl J Med 330, 1994
10. PETERSON J, ADLER S, BURKART J, et al: Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study. Ann Intern Med 123:754-762, 1995
11. MASCHIO G, ALBERTI D, JANIN G, et al: Effect of the angiotensin- converting enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group. N Engl J Med 334:939-945, 1996
12. RUGGENENTI P, PERNA A, GHERARDI G, et al: Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria. Lancet 354:359-364, 1999
13. PEDRINI MT, LEVEY AS, LAU J, et al: The effect of dietary protein restriction on the progression of diabetic and non-diabetic renal diseases: A meta-analysis. Ann Intern Med 124:627-632, 1996
14. FRIED LF, ORCHARD TJ, KASISKE BL: Effect of lipid reduction on the progression of renal disease: A meta-analysis. Kidney Int 59:260-269, 2001
15. JUNGERS P, MASSY Z, NGUYEN-KHOA T, et al: Longer duration of predialysis nephrological care is associated with improved long-term survival of dialysis patients. Nephrol Dial Transplant 16:2357-2364, 2001
16. RATCLIFFE PJ, PHILLIPS RE, OLIVER DO: Late referral for maintenance dialysis. BMJ 288:441-443, 1984
17. KHAN IH, CATTO GRD, EDWARD N, MACLEOD AM: Chronic renal failure: Factors influencing nephrology referral. Q J Med 87:559-564, 1994
18. SESSO R, BELASCO AG: Late diagnosis of chronic renal failure and mortality on maintenance dialysis. Nephrol Dial Transplant 11:2417-2420, 1996
19. RODERICK P, JONES C, DREY N, et al: Late referral for end-stage renal disease: A region-wide survey in the south west of England. Nephrol Dial Transplant 17:1252-1259, 2002
20. KINCHEN KS, SADLER J, FINK N, et al: The timing of specialist evaluation in chronic kidney disease and mortality. Ann Intern Med 137:479-486, 2002
21. AVORN J, BOHN RL, LEVY E, et al: Nephrologist care and mortality in patients with chronic renal insufficiency. Arch Intern Med 162:2002-2006, 2002
22. XUE J, PETER WS, EBBEN J, et al: Anemia treatment in the pre-ESRD period and associated mortality in elderly patients. Am J Kidney Dis 40:1153-1161, 2002
23. CHARLSON ME, POMPEI P, ALES KL, MACKENZIE CR: A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 40:373-383, 1987
24. DEYO RA, CHERKIN DC, CIOL MA: Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 45:613-619, 1992
25. BEDDHU S, BRUNS FJ, SAUL M, et al: A simple comorbidity scale predicts clinical outcomes and costs in dialysis patients. Am J Med 108:609-613, 2000
26. GHALI WA, QUAN H, BRANT R, et al: Comparison of 2 methods for calculating adjusted survival curves from proportional hazards models. JAMA 286:1494-1497, 2001
27. CAMPBELL JD, EWIGMAN B, HOSOKAWA M, VAN STONE JC: The timing of referral of patients with end-stage renal disease. Nephrol Dial Transplant 18:660-686, 1989
28. SCHMIDT RJ, DOMICO JR, SORKIN MI, HOBBS G: Early referral and its impact on emergent first dialyses, health care costs, and outcome. Am J Kidney Dis 32:278-283, 1998
29. ROUBICEK C, BRUNET P, HUIART L, et al: Timing of nephrology referral: Influence on mortality and morbidity. Am J Kidney Dis 36:35-41, 2000
30. Morbidity and mortality of dialysis, in NIH Consensus Statement, vol. 11, 1993, p. 1-33
31. RENAL PHYSICIAN ASSOCIATION AND ROYAL COLLEGE OF PHYSICIANS: Treatment of adult patients with renal failure, in Renal Physician Association and Royal College of Physicians, 2nd ed., London, 1997
32. MENDELSSOHN DC, BARRETT BJ, BROWNSCOMBE LM, et al: Elevated levels of serum creatinine: Recommendations for management and referral. CMAJ 161:413-417, 1999
33. AVORN J, WINKELMAYER WC, BOHN RL, et al: Delayed nephrologist referral and inadequate vascular access in patients with advanced chronic kidney failure. J Clin Epidemiol 55:711-716, 2002
34. XIA H, EBBEN J, MA J, COLLINS A: Hematocrit levels and hospitalization risk in hemodialysis patients. J Am Soc Nephrol 10:1309-1316, 1999
35. ARORA P, KAUSZ A, OBRADOR G, et al: Hospital utilization among chronic dialysis patients. J Am Soc Nephrol 11:740-746, 2000
36. GILL JS, ABICHANDANI R, KHAN S, et al: Opportunities to improve the care of patients with kidney transplant failure. Kidney Int 61:2193-2200, 2002
37. OBRADOR G, ROBERTS T, PETER WS, et al: Trends in anemia at initiation of dialysis in the United States. Kidney Int 60:1875-1884, 2001
38. MA J, EBBEN J, XIA H, COLLINS A: Hematocrit level and associated mortality in hemodialysis patients. J Am Soc Nephrol 10:610-619, 1999
39. BURTON C, ANSELL D, TAYLOR H, et al: Management of anaemia in United Kingdom renal units: A report from the UK Renal Registry. Nephrol Dial Transplant 15:1022-1028, 2000
40. FOLEY RN, PARFREY PS, HARNETT JD, et al: The impact of anemia on cardiomyopathy, morbidity and mortality in end-stage renal disease. Am J Kidney Dis 28:53-61, 1996
41. FOLEY RN, PARFREY PS: Anemia as a risk factor for cardiac disease in dialysis patients. Semin Dial 12:84-86, 1999
42. PARFREY PS, FOLEY RN, HARNETT JD, et al: Outcome and risk factors of ischemic heart disease in chronic uremia. Kidney Int 49:1428-1434, 1996
43. LEVIN A, SINGER J, THOMPSON CR, et al: Prevalent left ventricular hypertrophy in the predialysis population: Identifying opportunities for intervention. Am J Kidney Dis 27:347-354, 1996
44. SARNAK M, TIGHIOUART H, MANJUNATH G, et al: Anemia as a risk factor for cardiovascular disease in the Atherosclerotic Risk in Communities (ARIC) study. J Am Coll Cardiol 40:27-32, 2002
45. REVICKI D, BROWN R, FEENY D, et al: Health-related quality of life associated with recombinant human erythropoietin therapy for predialysis chronic renal disease patients. Am J Kidney Dis 25:548-554, 1995
46. ESCHBACH JW, AQUILING T, HALEY NR, et al: The long-term effects of recombinant human erythropoietin on the cardiovascular system. Clin Nephrol 38:S98-S103, 1992
47. LOWRIE EG, LEW NL: Death risk in hemodialysis patients: The predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis 15:458-482, 1990
48. ISEKI K, KAWAZOE N, FUKIYAMA K: Serum albumin is a strong predictor of death in chronic dialysis patients. Kidney Int 44:115-119, 1993
49. KAYSEN G, RATHORE V, SHEARER G, DEPNER T: Mechanisms of hypoalbuminemia in hemodialysis patients. Kidney Int 48:510-516, 1995
50. LAMEIRE N, BIESEN WV: The pattern of referral of patients with end-stage renal disease to the nephrologist-A European survey. Nephrol Dial Transplant 14(Suppl 6):16-23, 1999
51. PETERSON JC, ADLER S, BURKART JM, et al: Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study. Ann Intern Med 123:754-762, 1995
52. KLAHR S, LEVEY AS, BECK GJ, et al: The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group. N Engl J Med 330:877-884, 1994
53. Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia). Lancet 349:1857-1863, 1997
54. JAFAR TH, SCHMID CH, LANDA M, et al: Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data. Ann Intern Med 135:73-87, 2001
55. KASISKE BL: Hyperlipidemia in patients with chronic renal disease. Am J Kidney Dis 32:8142-156, 1998
56. Executive summary of the third report of the National Cholestrol Education Program (NCEP)-Expert panel on detection, evaluation, and treatment of high blood cholestrol in adults (ATP-III), NIH Publication No. 01-3670, 2001
57. LEVEY AS, BETO JA, CORONADO BE, et al: Controlling the epidemic of cardiovascular disease in chronic renal disease: What do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease. Am J Kidney Dis 32:853-906, 1998
58. NATIONAL KIDNEY FOUNDATION: K/DOQI clinical practice guidelines for nutrition in chronic renal failure. Am J Kidney Dis 35(Suppl 2):S56-S64, 2000
59. NKF-K/DOQI: Clinical practice guidelines for chronic kidney disease: Evaluation, classification and stratification. Am J Kidney Dis 39:S1-S246, 2002
60. RODERICK P, JONES C, TOMSON C, MASON J: Late referral for dialysis: Improving the management of chronic renal disease. QJ Med 95:363-370, 2002
61. STRIKER G: Report on a workshop to develop management recommendations for the prevention of progression in chronic renal disease. J Am Soc Nephrol 5:1537-1540, 1995